(Q24291767)

2

0 references

K L Lim

3

0 references

Y Tanaka

4

0 references

H Huang

5

0 references

J Gao

6

0 references

C A Ross

7

0 references

V L Dawson

8

0 references

T M Dawson

https://scigraph.springernature.com/pub.10.1038/nm1001-1144

9

0 references

language of work or name

English

0 references

publication date

October 2001

0 references

published in

Nature Medicine

0 references

volume

7

0 references

page(s)

1144-50

0 references

issue

10

0 references

exact match

0 references

cites work

Parkinson's disease. Second of two parts

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Pathology and biology of the Lewy body

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

New animal models for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Ubiquitin-mediated proteolysis: biological regulation via destruction

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Modes of regulation of ubiquitin-mediated protein degradation

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

The ubiquitin pathway in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Synphilin-1 is present in Lewy bodies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Oxidative stress and genetics in the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism.

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q.

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Familial juvenile parkinsonism: clinical and pathologic study in a family.

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021

Growth hormone effects on RNA and protein synthesis in liver

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1144

7 January 2021